Want to see CMPX full AI Analyst Report?
Compass Therapeutics (CMPX) Ownership Overview
12.75% Insiders
7.09% Mutual Funds
50.49% Other Institutional Investors
11.64% ETFs
18.03% Public Companies and
Individual Investors
The ownership structure of Compass Therapeutics (CMPX) stock is a mix of institutional, retail, and individual investors. Approximately 69.22% of the company’s stock is owned by Institutional Investors, 12.75% is owned by Insiders, and 18.03% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Oct 02, 2026 | xxxxxxxxxxxxx | $18400 | |
Sep 25, 2026 | xxxxxxxxxxxxx | $2850 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2026 | xxxxxxxxxxxxx | $1970860 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $2927548 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $50057 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $3048239 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 15,219,994 | Insider | 8.45% | 15,113,454 | |
| 7,190,811 | Institution | 3.99% | 7,140,475 | |
| 6,603,336 | Insider | 3.67% | 6,557,113 | |
| 5,901,798 | Institution | 3.28% | 5,860,485 | |
| 5,428,860 | Institution | 3.01% | 5,390,858 | |
| 5,403,438 | Institution | 3.00% | 5,365,614 | |
| 3,606,000 | Institution | 2.00% | 3,580,758 | |
| 1,632,670 | Institution | 0.91% | 1,621,241 | |
| 1,548,183 | Institution | 0.86% | 1,537,346 | |
| 1,423,822 | Institution | 0.79% | 1,413,855 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,901,798 | Institution | 3.28% | 5,860,485 | |
| 1,548,183 | Institution | 0.86% | 1,537,346 | |
| 1,423,822 | Institution | 0.79% | 1,413,855 | |
| 768,054 | Institution | 0.43% | 762,678 | |
| 646,144 | Institution | 0.36% | 641,621 | |
| 523,108 | Institution | 0.29% | 519,446 | |
| 370,944 | Institution | 0.21% | 368,347 | |
| 345,308 | Institution | 0.19% | 342,891 | |
| 211,802 | Institution | 0.12% | 210,319 | |
| 151,722 | Institution | 0.08% | 150,660 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,872,720 | Institution | 2.71% | 4,791,833 | |
| 4,190,754 | Institution | 2.33% | 10,015,902 | |
| 3,534,366 | Institution | 1.96% | 3,509,625 | |
| 1,821,580 | Institution | 1.01% | 4,353,576 | |
| 1,635,848 | Institution | 0.91% | 1,624,397 | |
| 1,204,348 | Institution | 0.67% | 1,195,918 | |
| 754,544 | Institution | 0.42% | 1,803,360 | |
| 410,710 | Institution | 0.23% | 407,835 | |
| 291,081 | Institution | 0.16% | 695,684 | |
| 265,359 | Institution | 0.15% | 260,954 |
FAQ
Who Owns Compass Therapeutics (CMPX)?
According to the latest TipRanks data, approximately 50.49% of the company's stock is held by institutional investors, 12.75% is held by insiders, and 18.03% is held by retail investors.
What percentage of Compass Therapeutics (CMPX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 50.49% of Compass Therapeutics (CMPX) stock is held by institutional investors.
What percentage of Compass Therapeutics (CMPX) stock is held by retail investors?
According to the latest TipRanks data, approximately 18.03% of Compass Therapeutics (CMPX) stock is held by retail investors.
Who owns the most shares of Compass Therapeutics (CMPX)?
Carl Gordon owns the most shares of Compass Therapeutics (CMPX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.